Factors Predict Low BMD in Pediatric Blood Cancer Survivors
THURSDAY, Oct. 3, 2019 -- Low bone mineral density (BMD) is common in childhood leukemia and lymphoma survivors, according to a study published online Sept. 19 in Cancer.
Hadley M. Bloomhardt, M.D., from the Yale School of Medicine in New Haven,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Childhood Cancer | Leukemia | Lymphoma | Pediatrics | Pharmaceuticals | Study | Yale